flanders.bio member events

Blockchain in Clinical Trials - How and Why Blockchain and Distributed Ledger Technologies (DLTs) are new disruptive approaches

BioBusiness Summer School is an introductory course for academics who are contemplating a career switch to industry and young professionals in their first industry jobs. This course will help you jumpstart your business career in the Life Sciences industry. During the five day programme you will learn the basics of the main business topics, such as product development, intellectual property rights, business models and finance. You will also gain insight into the world of Life Sciences companies, meet leading business people and expand your international network.

Crown Bioscience and Janssen Pharmaceutica cordially invite you to our second jointly organized symposium, this year discussing Cellular Therapies in Oncology and Beyond: from Drug Development to Clinical Applications on June 27th.

Join early stage companies, Johnson & Johnson experts, investors and enthusiasts in health technology to explore together the state-of-the-art in health tech platforms and how to leverage such innovative solutions for the benefit of patients and consumers.

In this workshop, Allen & Overy aims to tackle vital legal challenges a scale up life sciences company might typically face. Rather than giving highly technical advice on one particular issue, the workshop is aimed at providing a bird’s eye overview of attention points and creating appropriate reflexes when being confronted with an issue. In this respect, the workshop aims to tackle issues you might today already be confronted with, as well as issues which might become relevant to your company from a short to medium term perspective.

Exclusive command over your innovative technology underpins business success in the biotech and pharma space. Patents, which protect technical advancements are conceivably the most impactful and value-generating instrument in your ‘exclusivity toolbox’. To secure patents which accurately claim and describe the invented technology, dovetail with the existing patent portfolio and implement the overall business strategy, one must tap into diverse knowledge resources within an organisation. To this end, awareness of the key role played by patents and of the patenting process should be widely distributed throughout an organisation, and most certainly within R&D, marketing, legal and management.

The preservation of biological material is of primary interest for research but also for industrial applications. It is the mission of the BCCM consortium not only to preserve, but also to offer quality controlled, characterised and documented biological material. BCCM also offers its expertise through services and partnership projects.

Recent advances in technology now allow us to explore multiple aspects of heterogeneity at the single cell level. Nowhere is this more important than in the Central Nervous System (CNS), where cellular heterogeneity has profound effects on all aspects of normal brain function and behavior and explains important aspects of disease pathology.

What are the key drivers and resistors for development of diagnostics and therapeutics in rare diseases?

How to build a value proposition and sustainable business plan in this setting?

When moving outside R&D, which additional challenges arise?

How to design clinical trials and establish strategic partnerships?

Which efforts can be undertaken to ensure access and affordability of orphan drugs?

Are you orientating on the next steps in your career? Or are you an employer and wish to show job seekers what you have to offer? Join BCF Career Event on 14 November 2019 in Ghent ICC.

After two successful editions (organized in June 2015 & October 2017) featuring each time ~300 attendees, we are pleased to announce the 3^rdedition that will take place in December 2019.